Conference Coverage
Conference Coverage
Dr. C. Kent Osborne Previews the San Antonio Breast Cancer Symposium
Conference Coverage
More Bevacizumab Trials to Report Outcomes in San Antonio
Conference Coverage
San Antonio Breast Cancer Symposium: More to Come on 2011 Practice Changers
Conference Coverage
Cardiac Toxicity Not Seen 25 Years after Breast Radiation
Major Finding: There were no significant differences in major cardiac function parameters between women treated with modified radical mastectomy...
Conference Coverage
Older Women Lived Longer With Radiotherapy After Lumpectomy
Major Finding: The overall survival rate was 88.6% at 5 years with radiation and lumpectomy vs.
Conference Coverage
Everolimus Reduces Breast Cancer Treatment Effects in Bone
Major Finding: Treatment with everolimus and exemestane was associated with improved levels of bone-specific alkaline phosphatase, amino-terminal...
Conference Coverage
Experimental Drug Improves Muscle Strength in Cancer
Major Finding: The experimental drug enobosarm significantly improved physical function on a stair-climb test by 17% in hypogonadal men with...
Conference Coverage
Oral Taxane Shows Spunk in Metastatic Breast Cancer
Conference Coverage
Scalp Cooling Protects Against Chemotherapy-Induced Alopecia
Conference Coverage
Paclitaxel Matches New Drugs as First-Line Breast Cancer Therapy
Major Finding: With a median follow-up of 12 months, progression-free survival was 10.6 months with paclitaxel, which was comparable to nab-...